Trial
NCT03057990
Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Montefiore Medical Center
Collaborators
Albert Einstein College of Medicine
Condition
Myelodysplastic Syndromes
Intervention
Pyrimethamine
Why stopped
Study never opened; closed on 06/29/2021 due to no enrllment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-22